Use Of Breast Cancer Associated Membrane Proteins (BCMP) For treatment, Prophylaxis and Diagnosis Of Breast Cancer

Details for Australian Patent Application No. 2001233929 (hide)

International Classifications

Event Publications

8 September 2005 Application Accepted

Published as AU-B-2001233929

20 October 2005 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 29 Sep 2005. Address for service in Australia - Phillips Ormonde & Fitzpatrick Level 21 367 Collins Street Melbourne VIC 3000

12 January 2006 Standard Patent Sealed

2 March 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 29 Sep 2005

22 October 2009 Assignment Registered

Oxford Glycosciences (UK) Ltd. The patent has been assigned to UCB Pharma S.A.

15 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.